Nuzenio

Gurufocus Agios Pharmaceuticals

Gurufocus Agios Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 2 publisher sources 100/100 entity strength

Latest news

FARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:27:48 GMTAGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:47:42 GMTAgios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:56:15 GMTQ3 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocusGuruFocus · Sun, 02 Aug 2026 16:03:26 GMTAGIO Maintained by Citigroup -- Price Target Raised to $52.00 - GuruFocusGuruFocus · Fri, 31 Jul 2026 23:12:14 GMTAGIO SWOT Analysis: Financial Resilience Amidst Growing Product Pipeline Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 31 Jul 2026 04:19:19 GMTQ2 2026 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocusGuruFocus · Thu, 30 Jul 2026 12:00:00 GMTAgios Pharmaceuticals Inc (AGIO) (Q2 2026) Earnings Call Highlights: Strong Mitapivat Revenue ... - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 08:27:48 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocus
Fri, 07 Aug 2026 16:47:42 GMTAGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocus
Fri, 07 Aug 2026 06:56:15 GMTAgios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocus
Sun, 02 Aug 2026 16:03:26 GMTQ3 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Fri, 31 Jul 2026 23:12:14 GMTAGIO Maintained by Citigroup -- Price Target Raised to $52.00 - GuruFocus
Fri, 31 Jul 2026 04:19:19 GMTAGIO SWOT Analysis: Financial Resilience Amidst Growing Product Pipeline Revealed in 10-Q Filing - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gurufocus Agios Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.